Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CML therapeutic agents with reduced drug-resistance and side-effect comprising 1,6-disubstituted indole compounds

CML therapeutic agents with reduced drug-resistance and side-effect comprising 1,6-disubstituted indole compounds

US Patent 10130631 · Granted Nov 20, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridinyltriazine derivative having protein kinase inhibitory activity, and phar2025
Pyridinyltriazine derivative having protein kinase inhibitory activity, and phar2025
Pyridinyltriazine derivative having protein kinase inhibitory activity, and phar2025
Bicyclic urea kinase inhibitors and uses thereof2025
Pyrimidines as EGFR-inhibitors and methods of treating disorders2025
Imidazolyl kinase inhibitors and uses thereof2025
Heteroaryl derivative, method for producing same, and pharmaceutical composition2024
Heteroaryl derivative, method for producing same, and pharmaceutical composition2024
Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis2024
Uses of pyrimidopyrimidinones as SIK inhibitors2024
Type II raf kinase inhibitors2023
Bicyclic urea kinase inhibitors and uses thereof2023